HutchMED (China) LIMITED Proceeds from Sale of Equity Method Investments
HutchMED (China) LIMITED (HMDCF) reported Proceeds from Sale of Equity Method Investments of $608.50 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfEquityMethodInvestments · last filed 2025-08-07
| Period end | Proceeds from Sale of Equity Method Investments 6 month | Proceeds from Sale of Equity Method Investments 12 month |
|---|---|---|
| 2025-06-30 | $608.50M 6-K · filed 2025-08-07 | |
| 2021-12-31 | $159.12M 20-F · filed 2022-03-03 | |
| 2021-06-30 | $15.91M 6-K · filed 2022-08-01 |